Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.

This publication has 55 references indexed in Scilit:

• A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
  Diabetes Care, 1999
• Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet
  The American Journal of Cardiology, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998
• Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease
  The American Journal of Cardiology, 1996
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes
  Diabetes Care, 1995
• Primary and secondary prevention of myocardial infarction and strokes
  Journal Of Hypertension, 1993
• The Pharmacology of ATP-Sensitive Potassium Channels
  Annual Review of Pharmacology and Toxicology, 1993
• The sulfonylurea receptor
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
• RISK FACTORS FOR ISCHqMIC HEART-DISEASE IN NORMAL MEN AGED 40 Edinburgh?Stockholm Study
  The Lancet, 1978